Sangamo Therapeutics, Inc.
SGMO
$0.15
-$0.02-12.73%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -55.23% | -25.52% | 19.23% | 74.64% | 75.78% |
| Total Depreciation and Amortization | -25.16% | -18.79% | -23.26% | -47.95% | -54.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.75% | 31.96% | -57.16% | -86.13% | -87.65% |
| Change in Net Operating Assets | -52.26% | -193.72% | 249.76% | 202.29% | 193.79% |
| Cash from Operations | -102.44% | -44.79% | 33.39% | 79.29% | 78.46% |
| Capital Expenditure | 56.93% | 61.80% | 91.39% | 94.63% | 97.56% |
| Sale of Property, Plant, and Equipment | -- | -- | 210.74% | 1,336.22% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -100.00% | -100.00% |
| Cash from Investing | -106.83% | -100.27% | -98.33% | -98.62% | -98.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 416.33% | 148.91% | 190.58% | 104.94% | -40.34% |
| Repurchase of Common Stock | 55.55% | -140.28% | -164.03% | -182.95% | -326.68% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 520.71% | 149.32% | 192.04% | 101.03% | -49.88% |
| Foreign Exchange rate Adjustments | 2,127.72% | 299.76% | 16.24% | 2,429.03% | -122.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.16% | -583.81% | 41.24% | 129.74% | -17.39% |